Appetite Regulation: Helps manage hunger and reduce cravings
A method for preventing radiation-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, TRPV modulator, an MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of radiation therapy, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
The pursuit of effective loose skin treatments has driven considerable research interest in compounds that can stimulate the bodys own regenerative capabilities
For chronic pain patients, Lyrica can be a good, non-opioid option
Generalized hyperalgesia and allodynia following abrupt cessation of subcutaneous ketamine infusion
Purity Standards Research-grade peptides should meet 98% purity by HPLC